ArticleMedicine2026
Trends in heart failure mortality among patients with rheumatoid arthritis in the United States (1999-2020): A nationwide cross-sectional analysis of the CDC WONDER database.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid Arthritis (RA) is a known risk factor for heart failure (HF) due to its chronic autoimmune-mediated inflammation. However, data on trends of Rheumatoid arthritis associated HF mortality in the United States (U.S.) remain limited. This study comprehensively explores the trends in rheumatoid arthritis associated mortality attributable to HF patients in the United States. A retrospective analysis was performed using data from the Centers for Disease Control and Prevention Wide-Ranged Online Data for Epidemiologic Research database. We obtained age-adjusted mortality rates (AAMR) per 100,000 population and used Joinpoint regression to calculate the annual percentage change. The results were analyzed by year, sex, race, and geographic region to identify patterns in mortality from RA-associated HF. Between 1999 and 2020, 28,750 cases of cardiac failure in RA patients aged 55 and older were documented. In 1999, the AAMR was 2.5; by 2020, it was 1.9 (annual percentage change: -4.05 [95% CI; -6.30 to -3.13]). Sex differences did not go away, either, with women continuously having a higher AAMR (2.3) than men (1.2). The highest AAMR was 2.0 for non-Hispanic White, 1.5 for NH Black or African American, and 1.3 for Hispanic or Latino. Geographically, the Northeast had the lowest AAMR (1.4), while the Midwestern region had the highest (2.3). Nonmetropolitan areas had a greater AAMR (2.6) than metropolitan areas (1.7). Interestingly, Vermont, Oregon, Minnesota, Montana, South Dakota, and North Dakota had the highest AAMRs. Between 1999 and 2020, RA-associated HF mortality declined overall but rose again after 2018, particularly among women, non-Hispanic Whites, and residents of rural Midwestern states. Persistent disparities by sex, race, and geography highlight the need for targeted cardiovascular and rheumatologic care strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.